Cell-Easy vs Cell Therapies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cell-easy/celltherapies

Category	Cell-Easy	Cell Therapies
Listed site	cdmo	cdmo
Summary	Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.	GMP contract manufacturer of autologous and allogeneic cell therapies from first-in-human trials through commercial supply, with two decades of experience in CAR-T, mesenchymal stromal cells, TILs, and pluripotent stem cell derivatives. Offers end-to-end cold chain management, process development, quality control analytics, and regulatory consulting across Australia and Asia-Pacific.
Services	Cell Therapy Manufacturing Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Technology Transfer Process Development CMC Analytical Development Quality Control Testing Cold-Chain Storage & Logistics CMC Regulatory Submission Support
Modalities	Cell Therapy	Cell Therapy Gene Therapy
Indications	Oncology Immunology	Oncology
Locations	Headquarters, Toulouse, Occitanie, France	Headquarters / Manufacturing & Development, Melbourne, Victoria, Australia
Certifications	Data not yet provided.	TGA · Identifier: TGA-licensed FDA · Identifier: FDA inspection-ready PMDA · Identifier: PMDA inspection-ready EMA · Identifier: EMA inspection-ready
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.